Entecavir Tablets 0.5?mg Low Price Wholesale Comparison

Entecavir Tablets 0.5?mg Low Price Wholesale Comparison

$2.00

Renhe Entecavir Tablets contain 0.5?mg entecavir per tablet in two blisters totaling 28 tablets per bottle. Manufactured by Jiangxi Pharmaceutical Co., Ltd., approved under NMPA H20213196. Designed for preclinical research in antiviral therapy against chronic hepatitis B.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Entecavir is a potent nucleoside reverse transcriptase inhibitor (NRTI) effective against hepatitis B virus (HBV). These tablets are suitable for pharmacological and virology research involving antiviral efficacy, resistance mechanisms, and pharmacokinetics in hepatocyte models. The 0.5?mg strength aligns with standard dosing in chronic HBV studies.


Entecavir Tablets Product Specifications

ParameterDetails
Product NameEntecavir Tablets (Renhe)
Generic NameEntecavir
CAS Number142217?69?4
Molecular FormulaC??H??N?O?
Molecular Weight~277.28?g/mol
Dosage FormOral tablet
Strength0.5?mg per tablet
Pack Size14 tablets ×?2 blisters = 28 tablets per bottle
NMPA Approval No.H20213196
Drug Standard Code86905388003431
ManufacturerJiangxi Pharmaceutical Co., Ltd.
Barcode6903919183458
Storage ConditionsStore <?25?°C, sealed, protect from moisture and light
Intended UseFor laboratory and preclinical HBV antiviral research

Entecavir Tablets Mechanism of Action

Entecavir acts as a guanosine analogue that inhibits HBV reverse transcriptase, preventing viral DNA synthesis in infected cells. It offers high antiviral potency with minimal resistance, making it a valuable compound in chronic HBV research.


Entecavir Tablets Research Application Areas

  • Chronic hepatitis B viral suppression studies

  • Antiviral resistance and mutation modeling

  • Pharmacokinetic and bioavailability analysis

  • Combination therapy with other antivirals (e.g. tenofovir, lamivudine)

  • In vitro hepatocyte and in vivo animal studies


Safety & Handling

  • Handling: Use standard lab PPE—gloves, coat, goggles; avoid ingestion.

  • Storage: Maintain below 25?°C, sealed and dry.

  • Precautions: Designed for laboratory use only; not for human or veterinary administration.


Core Keywords

entecavir tablets, entecavir 0.5mg, CAS 142217-69-4, H20213196, HBV research tablet, NRTI antiviral research, Renhe entecavir, wholesale entecavir


Research Use Disclaimer

This product is for laboratory and preclinical research use only. It is not approved for clinical, therapeutic, diagnostic, or veterinary applications. Misuse may carry legal or health risks. Use under approved institutional protocols.

Additional information

Weight1 kg
Dimensions36 × 26 × 36 cm

Reviews

There are no reviews yet.

Be the first to review “Entecavir Tablets 0.5?mg Low Price Wholesale Comparison”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare